San Miguel, Peru Clinical Trials

A listing of San Miguel, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 99 clinical trials
Evaluating Newly Approved Drugs for Multidrug-resistant TB

endTB Clinical Trial a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of five new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB).

linezolid
bedaquiline
levofloxacin
pyrazinamide
delamanid
Socios En Salud
 (4.0 away) Contact site
  • 223 views
  • 20 Sep, 2021
  • +7 other locations
A Study to Determine the Efficacy Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) Versus Meropenem (MER) Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

A Phase 3 comparative study to determine the efficacy, safety and tolerability of Aztreonam-Avibactam (ATM-AVI) Metronidazole (MTZ) versus Meropenem (MER) Colistin (COL) for the treatment of serious infections due to Gram negative bacteria.

ct scan
ATM
metronidazole
antibiotics
meropenem
Clinica Internacional - Unidad de Investigacion de la Clinica Internacional
 (4.7 away) Contact site
  • 193 views
  • 26 Sep, 2021
  • +189 other locations
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

alopecia
systemic therapy
lung carcinoma
Novartis Investigative Site
 (5.0 away) Contact site
  • 645 views
  • 21 Sep, 2021
  • +416 other locations
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT) when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) as part of treatment for latent TB infection (LTBI) in HIV-1 and LTBI co-infected individuals.

hiv-1 antigen
skin test
total bilirubin
immune globulin
hiv-1 rna measurement
Barranco CRS
 (7.6 away) Contact site
  • 0 views
  • 30 Aug, 2021
  • +10 other locations
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).

fever
chest x-ray
mechanical ventilation
SARS
pneumonia
Clinica Providencia
 (0.7 away) Contact site
  • 122 views
  • 17 Mar, 2021
  • +32 other locations
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of two new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB) with fluoroquinolone resistance.

linezolid
bedaquiline
linezolid pill
delamanid
fluoroquinolones
Socios En Salud
 (4.0 away) Contact site
  • 94 views
  • 17 Sep, 2021
  • +5 other locations
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency. The intention of the study is to demonstrate that in participants with mHSPC, the …

Research Site
 (2.9 away) Contact site
  • 111 views
  • 18 Sep, 2021
  • +290 other locations
A Study of V937 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)

The purpose of this study is to evaluate the safety, tolerability, and efficacy in participants with advanced/metastatic or recurrent malignancies who receive V937 in Combination with Pembrolizumab (MK-3475). The primary objective for Part 1 is to evaluate the objective response rate, and the primary objective for Part 2 is to …

fluoropyrimidine
carcinoma
breast cancer
x-rays
trastuzumab
Clinica San Gabriel ( Site 0097)
 (0.5 away) Contact site
  • 0 views
  • 18 Sep, 2021
  • +25 other locations
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

This is a randomized, double-blind, multicenter, global Phase 3 study to assess the efficacy and safety of monalizumab and cetuximab, compared to placebo and cetuximab, in patients with recurrent or metastatic head and neck cancer.

Research Site
 (3.1 away) Contact site
  • 0 views
  • 05 Sep, 2021
  • +166 other locations
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

rheumatism
immunosuppressive agents
lupus
corticosteroids
sjogren's syndrome
Sl0043 60008
 (4.0 away) Contact site
  • 10 views
  • 12 Sep, 2021
  • +159 other locations